周边动脉疾病市场规模、份额及成长分析（按类型、治疗方法、疾病、给药途径、最终用户和地区）—产业预测，2025 年至 2032 年

预计 2023 年周边动脉疾病市场规模将达到 53 亿美元，从 2024 年的 58.5 亿美元成长到 2032 年的 129.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.4%。

截至 2023 年 10 月，约有 650 万 40 岁及以上的美国人患有周边动脉疾病(PAD)，市场调查显示，非裔美国人的盛行率更高。老化社会是周边动脉疾病 (PAD) 患者数量增加的主要原因，因为患病风险会随着老龄化的增长而增加。与人口结构变化同步的是，用于诊断、管理和治疗週边动脉疾病 (PAD) 的产品核准激增。这些因素的结合增加了周边动脉疾病的整体风险，凸显了与老龄化相关的趋势、疾病盛行率的增加和医疗保健技术进步之间的复杂交互作用。了解这些动态对于寻求有效解决美国日益加重的周边动脉疾病负担的相关人员来说至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

全球周边动脉疾病市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 血管成形术用气球
• 斑块修饰装置
• 外周支架
• 週边导管
• 血流动力学血流调节器
• 下腔静脉 (IVC) 过滤器
• 周边设备

全球周边动脉疾病市场规模（按治疗方法和复合年增长率） (2025-2032)

• 市场概览
• 装置
  • 支架
  • 气球
  • 动脉粥状硬化斑块切除设备
• 导管
  • 药物释放型导管
  • 球囊导管
  • 导管导引线
• 斑块修饰装置
• 血流动力学血流调节器
• 其他的

全球周边动脉疾病市场规模（依疾病类型及复合年增长率）（2025-2032）

• 市场概览
• 降血脂药物
• 三重H疗法
• 血糖值调节剂
• 溶栓药物
• 心臟正性肌力药
• 血栓溶解剂
• 抗发炎剂

全球周边动脉疾病市场规模（依给药途径及复合年增长率）（2025-2032）

• 市场概览
• 口服
• 肠外
• 其他的

全球周边动脉疾病市场规模（依最终用户和复合年增长率）（2025-2032 年）

• 市场概览
• 医院和诊所
• 门诊外科诊所

全球周边动脉疾病市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Philips（Netherlands）
• Terumo Corporation（Japan）
• Cook Medical（USA）
• Cardinal Health, Inc.（USA）
• B. Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• BIOTRONIK SE & Co. KG（Germany）
• Endologix, Inc.（USA）
• Gore Medical（USA）
• Penumbra, Inc.（USA）
• AngioDynamics, Inc.（USA）
• Johnson & Johnson（USA）
• Bayer AG（Germany）

结论和建议

Peripheral Artery Disease Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.91 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

As of October 2023, market insights reveal that around 6.5 million Americans aged 40 and older are living with Peripheral Artery Disease (PAD), with heightened susceptibility observed among African Americans. The aging population significantly drives the rise in PAD cases, as risks increase with age. In tandem with this demographic shift, there has been a surge in product approvals aimed at the diagnosis, management, and treatment of PAD. This combination of factors enhances the overall risk of developing PAD, highlighting the complex interplay of age-related trends, increasing disease prevalence, and technological advancements in healthcare. Understanding these dynamics is crucial for stakeholders aiming to address the growing burden of PAD in the United States effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segments Analysis

Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Artery Disease Market

The growing prevalence of elderly individuals affected by diabetes and hypertension serves as a critical driver for the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and hypertension contribute to the narrowing and hardening of arterial walls, which in turn restricts blood flow to the limbs, thus increasing the likelihood of PAD. As the number of seniors facing these health challenges continues to rise, the demand for effective PAD treatments and interventions is anticipated to grow, further propelling the market forward.

Restraints in the Peripheral Artery Disease Market

The anticipated recurrence of peripheral artery disease (PAD) following treatment is expected to present a significant barrier to the growth of the peripheral artery disease market in the upcoming years. Despite advancements in medical technology and treatment options, the risk of PAD relapse remains a considerable obstacle to continuous market development. Moreover, concerns related to product recalls within the industry may exacerbate difficulties for the PAD market in the short term. Such recalls can undermine consumer trust, invite increased regulatory scrutiny, and require corrective actions, all of which can hinder overall market growth and stability. Addressing these challenges will necessitate a collaborative approach from stakeholders to effectively manage disease and ensure product safety, thereby supporting the ongoing development of effective therapies for peripheral artery disease.

Market Trends of the Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) market is poised for significant growth, driven by the increasing prevalence of the disease and a surge in product approvals by regulatory bodies. As PAD, characterized by the narrowing of arteries that supply blood to the limbs, continues to affect a larger segment of the population, the demand for advanced diagnostic and therapeutic solutions becomes paramount. Recent advancements in medical technologies yield innovative treatments and management strategies, directly addressing the complexities of PAD. This favorable landscape indicates a robust market expansion, creating substantial opportunities for stakeholders in the healthcare sector over the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Peripheral Artery Disease Market Size by Type & CAGR (2025-2032)

• Market Overview
• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava (IVC) Filters
• Peripheral Accessories

Global Peripheral Artery Disease Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Device
  • Stents
  • Balloons
  • Atherectomy Devices
• Catheters
  • Drug-Eluting Catheters
  • Balloon Catheters
  • Guidewires
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Others

Global Peripheral Artery Disease Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs,
• Inotropes,
• Thrombolytic Agents,
• Anti-Inflammatory Agents

Global Peripheral Artery Disease Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Peripheral Artery Disease Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Clinics

Global Peripheral Artery Disease Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Disease, Route of Administration, End User)
  • US
  • Canada
• Europe (Type, Treatment, Disease, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Disease, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Disease, Route of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Disease, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations